UK Life Sciences Company Directory

Long-read RNA sequencing platform for cancer biomarker discovery and diagnostics

Wobble Genomics is a Scottish biotechnology company developing long-read RNA sequencing technologies for biomarker discovery and cancer diagnostics. Its core platform combines a biochemical method to enrich rare and low-abundance full-length RNA transcripts, with a bioinformatics pipeline for novel transcript…

Tension-preserved human skin models for dermatology and drug testing

Ten Bio is a contract research organisation providing physiologically tensioned human skin models for pharmaceutical, dermatology and cosmetic research. Its patented TenSkin platform maintains full-thickness, ethically sourced surgical skin with its barrier, appendages and minor cell populations, preserving functional…

Multiplex PCR and NGS diagnostics for cancer and infection

GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…

Analytical instrumentation for life science, clinical and industrial research

Shimadzu UK is the British subsidiary of Shimadzu Corporation, a global manufacturer of analytical and measuring instruments. Its UK portfolio spans liquid and gas chromatography, mass spectrometry, spectroscopy, environmental monitoring, and materials testing systems serving pharmaceutical, biotechnology, clinical,…

Graph AI platform for crop gene target discovery and precision breeding

Biographica is a London agbiotech developing a graph machine learning platform to identify and validate gene editing targets for crop improvement. The platform integrates genomic, transcriptomic, and scientific literature data within knowledge graphs, combining in silico modelling with in vivo validation at Rothamsted…

Aquaculture genetics services and genomic selective breeding programmes

Xelect is a Scottish genetic services company providing selective breeding programme management and genomic analysis for aquaculture producers worldwide. The company manages over 30 active programmes across 16 species, including salmon, trout, shrimp, sea bass, and tilapia, combining high-throughput SNP genotyping…

Enzyme-enabled precision molecular editing for therapeutic discovery

X-Genix is a biotechnology company developing enzyme-enabled methods for selective molecular modification in drug discovery. Its platform integrates engineered biological catalysts, synthetic chemistry and machine learning to modify small molecules and complex biomolecules at defined sites. This provides access to…

AI-powered molecular design software for medicinal chemists

deepmirror is a software company developing an AI-powered drug design application for medicinal chemists. Its no-code interface integrates generative molecular design with predictive modelling of key drug properties including target affinity, ADMET profiles and solubility, enabling hit-to-lead and lead optimisation…

UK learned society for pharmacology and medicines research

The British Pharmacological Society (BPS) is a UK membership charity dedicated to promoting and advancing all disciplines of pharmacology in the discovery, development, and use of medicines. It supports a global community of over 4,500 members across more than 60 countries through scientific publishing, conferences,…

Non-invasive oral cancer screening using genomics and cell-free DNA

Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with saliva-based sample collection. The platform is designed to enable early detection of oral cancer through routine dental appointments,…

Digital microscope platform for veterinary parasite diagnostics

Techion (UK) is the UK subsidiary of New Zealand-founded Techion Group, developer of an integrated digital diagnostics platform for parasite management in production animals. Its FECPAKG2 system combines a portable digital microscope with cloud-based image analysis and decision support software, enabling on-farm…

Target discovery platform and antibody-based therapies for oncology

Oxford BioTherapeutics is an Oxford-based clinical-stage oncology company discovering and developing first-in-class antibody-based cancer therapies. Its proprietary platform identifies novel membrane protein targets directly from patient tumour samples, enabling the development of ADCs, immuno-oncology antibodies,…

Antibody therapeutics for inflammatory and autoimmune disease

MabGalaxy develops antibody therapeutics for inflammatory and autoimmune diseases, with scientific operations linked to Cambridge's Babraham Research Campus. Its discovery approach combines immune-system biology with artificial intelligence to support antibody design and selection. The company aims to shorten the…

Precision fermentation and bio-based ingredients for food and feed

Mycofeast is an Oxford-headquartered industrial biotechnology company developing fermentation-derived ingredients for human and animal nutrition. It combines precision and biomass fermentation with microbial strain development and bioprocess scale-up to develop functional beverage ingredients, dairy proteins,…

Automated on-demand DNA synthesis hardware for research laboratories

AmpliSynth is an instruments company developing automated DNA synthesis hardware for in-house, same-day gene production. Its platform uses enzymatic chemistry to synthesise custom DNA sequences directly within research laboratories, removing dependence on external suppliers and eliminating multi-week lead times…

Clinical-stage oncology biopharma developing the bispecific antibody ivonescimab

Summit Therapeutics is a clinical-stage oncology company with UK research operations originating from VASTox, a University of Oxford spin-out. The company's lead candidate, ivonescimab, is a bispecific antibody targeting PD-1 and VEGF, in-licensed from Akeso and now in multiple global Phase III trials across non-small…

Plasmonic PCR diagnostics for rapid infectious disease detection

RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…

Culturing microbial dark matter to discover novel antimicrobials and bioactives

Bactobio is a biotechnology company using synthetic biology, next-generation sequencing, and machine learning to culture the vast majority of environmental microbes that have previously been unculturable. Access to this largely unexplored bioresource enables systematic discovery of novel antimicrobial compounds and…

Xeno nucleic acid binders for targeted drug delivery

Xterna is a biotechnology company developing cell-specific molecular binders composed of xeno nucleic acids (XNAs), chemically modified nucleic acids distinct from naturally occurring DNA and RNA. XNA-based binders are engineered to target cell types that evade conventional antibody-based approaches, enabling drug…

Specialist CRO for rare disease drug development and commercialisation

TMC Pharma Services is a contract research organisation specialising in drug development support for rare and orphan diseases. The company serves small and mid-sized biotech and biopharma clients across the full development lifecycle, providing regulatory affairs, clinical development, pharmacovigilance, medical…